X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (21) 21
life sciences & biomedicine (20) 20
humans (16) 16
female (10) 10
heart failure (10) 10
double-blind method (9) 9
male (9) 9
cardiovascular system & cardiology (8) 8
aged (7) 7
cardiac & cardiovascular systems (7) 7
aldosterone (6) 6
diabetic nephropathies - drug therapy (6) 6
mineralocorticoid receptor antagonists (6) 6
mineralocorticoid receptor antagonists - therapeutic use (6) 6
naphthyridines - administration & dosage (6) 6
naphthyridines - adverse effects (6) 6
diabetes (5) 5
finerenone (5) 5
heart failure - drug therapy (5) 5
middle aged (5) 5
spironolactone - analogs & derivatives (5) 5
albuminuria - drug therapy (4) 4
antagonist (4) 4
chronic kidney disease (4) 4
clinical trials (4) 4
diabetes mellitus, type 2 - complications (4) 4
diabetic nephropathies (4) 4
mineralocorticoid receptor (4) 4
mineralocorticoid receptor antagonists - adverse effects (4) 4
naphthyridines - therapeutic use (4) 4
research (4) 4
spironolactone - therapeutic use (4) 4
adult (3) 3
albuminuria (3) 3
arabidopsis - genetics (3) 3
arabidopsis proteins - genetics (3) 3
arabidopsis proteins - metabolism (3) 3
bay 94-8862 (3) 3
cell biology (3) 3
clinical (3) 3
clinical medicine (3) 3
creatinine - urine (3) 3
diabetic nephropathies - urine (3) 3
dose-response relationship, drug (3) 3
glomerular filtration rate - drug effects (3) 3
kidney (3) 3
klinisk medicin (3) 3
life sciences (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
mineralocorticoid (3) 3
mineralocorticoid receptor antagonists - administration & dosage (3) 3
outcomes (3) 3
physiological aspects (3) 3
plant sciences (3) 3
potassium - blood (3) 3
proteins (3) 3
task-force (3) 3
urology & nephrology (3) 3
worsening heart failure (3) 3
abridged index medicus (2) 2
administration, oral (2) 2
albumin (2) 2
albuminuria - etiology (2) 2
angiotensin receptor antagonists - therapeutic use (2) 2
angiotensin-converting enzyme inhibitors - therapeutic use (2) 2
animals (2) 2
arabidopsis thaliana (2) 2
biochemistry & molecular biology (2) 2
biology and life sciences (2) 2
blood pressure (2) 2
blood pressure - drug effects (2) 2
brain natriuretic peptide (2) 2
cardio-renal syndrome - drug therapy (2) 2
care and treatment (2) 2
cell cycle (2) 2
cell proliferation (2) 2
chronic disease (2) 2
complications and side effects (2) 2
cyclin-dependent kinases - metabolism (2) 2
diabetes mellitus (2) 2
diabetes mellitus, type 2 (2) 2
diabetic nephropathies - physiopathology (2) 2
diabetic nephropathy (2) 2
dosage and administration (2) 2
double-blind (2) 2
endocrinology & metabolism (2) 2
eplerenone (2) 2
fasttrack clinical research (2) 2
general & internal medicine (2) 2
genes, cdc - physiology (2) 2
glomerular filtration rate (2) 2
heart failure - complications (2) 2
heart failure - physiopathology (2) 2
hyperkalemia (2) 2
hyperkalemia - chemically induced (2) 2
internal medicine (2) 2
japan (2) 2
japanese (2) 2
medicine, general & internal (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2015, Volume 314, Issue 9, pp. 884 - 894
IMPORTANCE: Steroidal mineralocorticoid receptor antagonists, when added to a renin-angiotensin system blocker, further reduce proteinuria in patients with... 
Blood Pressure | Creatinine | Glomerular Filtration Rate | Diabetic Nephropathies | Double-Blind Method | Drug Administration Schedule | Naphthyridines | Administration, Oral | Angiotensin Receptor Antagonists | Humans | Middle Aged | Male | Albuminuria | Incidence | Dose-Response Relationship, Drug | Hyperkalemia | Analysis of Variance | Angiotensin-Converting Enzyme Inhibitors | Least-Squares Analysis | Female | Aged | Diabetes Mellitus, Type 2 | Mineralocorticoid Receptor Antagonists | Potassium | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Naphthyridines - adverse effects | Diabetic Nephropathies - drug therapy | Diabetes Mellitus, Type 2 - ethnology | Glomerular Filtration Rate - drug effects | Diabetic Nephropathies - physiopathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hyperkalemia - epidemiology | Blood Pressure - drug effects | Diabetes Mellitus, Type 2 - complications | Diabetic Nephropathies - urine | Diabetes Mellitus, Type 2 - urine | Diabetic Nephropathies - ethnology | Creatinine - urine | Mineralocorticoid Receptor Antagonists - therapeutic use | Albuminuria - drug therapy | Hyperkalemia - chemically induced | Potassium - blood | Angiotensin Receptor Antagonists - therapeutic use | Naphthyridines - administration & dosage | Proteins | Clinical trials | Side effects | Diabetes | Antagonist drugs | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of diabetes and its complications, ISSN 1056-8727, 04/2017, Volume 31, Issue 4, pp. 758 - 765
Abstract Aims Finerenone (BAY 94–8862) is a novel non-steroidal mineralocorticoid receptor antagonist. The aim of this study was to compare the efficacy and... 
Endocrinology & Metabolism | Type 2 diabetes | Diabetic nephropathy | Albuminuria | Finerenone | MRA | Biomarkers - urine | Follow-Up Studies | Naphthyridines - adverse effects | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Diabetic Nephropathies - blood | Dose-Response Relationship, Drug | Drug Therapy, Combination - adverse effects | Glomerular Filtration Rate - drug effects | Diabetic Nephropathies - physiopathology | Renal Insufficiency - physiopathology | Female | Renal Insufficiency - complications | Renal Insufficiency - drug therapy | Diabetes Mellitus, Type 2 - complications | Kidney - physiopathology | Diabetic Nephropathies - urine | Mineralocorticoid Receptor Antagonists - administration & dosage | Reproducibility of Results | Kidney - drug effects | Albuminuria - etiology | Double-Blind Method | Japan | Mineralocorticoid Receptor Antagonists - adverse effects | Renal Insufficiency - metabolism | Biomarkers - blood | Albuminuria - prevention & control | Disease Progression | Mineralocorticoid Receptor Antagonists - therapeutic use | Naphthyridines - therapeutic use | Renin-Angiotensin System - drug effects | Aged | Naphthyridines - administration & dosage | Clinical trials | Diabetic nephropathies | Diabetes therapy | Medical research | Albumin | Medicine, Experimental | Drug discovery | Index Medicus
Journal Article
Journal Article
Children (Basel), ISSN 2227-9067, 07/2019, Volume 6, Issue 7, p. 82
Accountable care organizations (ACOs) have emerged as an effective healthcare delivery model for managing quality and cost at a population level. Within ACOs,... 
Life Sciences & Biomedicine | Pediatrics | Science & Technology | pharmacist | population health management | medication management | quality improvement | accountable care organization
Journal Article
Current opinion in nephrology and hypertension, ISSN 1062-4821, 09/2015, Volume 24, Issue 5, pp. 417 - 424
Journal Article
Journal Article
Journal Article
Book Chapter
European journal of heart failure, ISSN 1388-9842, 09/2012, Volume 14, Issue 9, pp. 1056 - 1066
Journal Article
Journal Article